Skip to main content Back to Top
Advertisement

4/3/2020

Prednisolone Oral Solution

Products Affected - Description

    • Prednisolone oral solution, Akorn, 3 mg/mL, 240 mL bottle, NDC 50383-0042-24
    • Prednisolone oral solution, Akorn, 3 mg/mL, 480 mL bottle, NDC 50383-0042-48
    • Prednisolone oral solution, Akorn, 1 mg/mL, 120 mL bottle, NDC 50383-0040-04

Reason for the Shortage

    • Akorn did not provide a reason for the shortage.
    • Pharmaceutical Associates Inc. has prednisolone oral solution available.
    • Seton Pharmaceuticals has prednisolone oral solution available.

Available Products

    • Prednisolone oral solution, Pharmaceutical Associates, Inc., 2 mg/mL, 237 mL bottle, NDC 00121-0773-08
    • Prednisolone oral solution, Pharmaceutical Associates, Inc., 3 mg/mL, 237 mL bottle, NDC 00121-0759-08
    • Prednisolone oral solution, Pharmaceutical Associates, Inc., 4 mg/mL, 237 mL bottle, NDC 00121-0777-08
    • Prednisolone oral solution, Seton Pharmaceuticals, 1 mg/mL, 120 mL bottle, NDC 13925-0166-04

Estimated Resupply Dates

    • Akorn has prednisolone 3 mg/mL in 120 mL, 240 mL, and 480 mL bottles on back order and the company cannot estimate a release date. The 240 mL and 480 mL bottles are available with short expiration dating.

Updated

Updated April 3, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 13, 2019 by Rachael Freeman, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.